In daily clinical routine, surrogate intrinsic subtypes are defined using histologicaly and immunohistological analysis of proteins such as estrogen and progesterone receptors, HER2, tumor grading and the proliferation marker Ki67. Here, ERBB2 is linked to neoplasm.